Until sex-specific risk is better understood, prevention and management of stroke and cardiovascular risk factors remains essentially the same for men and women. Disclosures Writing Group Disclosures Writing Group Member Employment Research Grant Other Research Support Speakers Bureau/ Honoraria Expert Witness Ownership Interest Consultant/ Advisory Board Other Cheryl Bushnell Wake Forest School of Medicine NIH/NINDS World Federation of Neurology None None None None None Louise D. McCullough University of Connecticut NIH/NINDS None Genentech* None None None None Issam A. Awad University of Chicago NIH/NINDS None None None None None None Monique V. Chireau Duke University Medical Center None None None None None None None Wende N. Fedder Alexian Brothers Health System None None None None None None None Karen L. Furie The Warren Alpert Medical School of Brown University/ Lifespan AHA ; NINDS None None None None UpToDate* JNNP Deputy Editor ; Stroke Vice Editor Virginia J. Howard University of Alabama at Birmingham NIH None None None None Spouse has relationship with Abbott Vascular*; spouse has relationship with Bayer* None Judith H. Lichtman Yale University AHA ; NINDS None None None None None None Lynda D. Lisabeth University of Michigan NIH None None None None None None Ileana L. Pi a Montefiore Medical Center None None None None None None None Mathew J. Reeves Michigan State University None None None None None None None Kathryn M. Rexrode Brigham and Women s Hospital NIH/NHLBI None None None None None None Gustavo Saposnik University of Toronto None None None None None Bayer* None Vineeta Singh University of California, San Francisco None None None None None None None Amytis Towfighi University of Southern California; Rancho Los Amigos National Rehabilitation Center AHA ; NIH/ NINDS None Boehringer Ingelheim* None None None None Viola Vaccarino Emory University None None None None None None None Matthew R. Walters University of Glasgow AstraZeneca*; GlaxoSmithKline*; Lundbeck*; Menarini*; Microtransponder, Inc*; Roche* None None None None Bayer*; Lundbeck*; UCB Pharma* None This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. 